Breadcrumb What we do | Member benefits Learning and development Organisational leadership Organisational leadership The UICC's organisational leadership workstream is designed to provide leaders in cancer organisations at all levels with spaces to acquire new skills, and opportunities to collaborate and take action together. Go to section Objectives Latest activities Partners Leadership at crossroads Through the onset of COVID-19, leadership across cancer organisations has been put decisively to the test, with traditional operating models upended, greater adoption of digital technologies and an uncertain strategic environment. As the cancer community moves on from the immediate crisis-response mode and emerge into a changed landscape, the ability of leaders and organisations to draw lessons from what has passed and make decisions amid the uncertainty will be critical to the resilience and success of the cancer community going forward. The UICC's organisational leadership workstream is designed to respond to the increasingly complex and uncertain operating environment by providing leaders in cancer organisations at all levels with spaces to take stock of the post-pandemic realities, platforms to explore the mindsets, skills and practices now called for, and opportunities to collaborate and take action together. The workstream builds on flagship initiatives, such as the Young Leaders programme, and the CEO Programme, expanding the approach through a refreshed combination of virtual and in-person learning and networking opportunities aimed at leaders across multiple levels, whether seasoned CEOs or emerging managers, patient advocates or healthcare executives, scientists in the lab or health practitioners on the frontline. Objectives By leveraging UICC platforms, as well as catalysing external leadership expertise to design targeted learning offers, the workstream aims to deliver the following objectives: Improve the capabilities of UICC members to lead the cancer community past COVID-19 Build management and organisational know-how across the UICC membership Nurture a community of emerging professionals to become future leaders in cancer control Create spaces for all UICC communities to discuss emerging leadership trends and explore collaborations Celebrate good practices and recognise excellence in organisational leadership for cancer control Latest activities and opportunities Essentials of leadership and management for civil society organisations (CSOs) in cancer control Digital leadership training programme Read more 'Leading questions' Virtual Dialogue series Working with and through partners The UICC's leadership offer is only possible thanks to support and expertise from partners across UICC's communities. The workstream is supported by MSD as a founding partner with whom UICC has enjoyed a strong, several-years-long, partnership on leadership through the CEO Programme, and benefits from knowledge support by a number of organisations which have informed and contributed expertise to individual activities. If your organisation is interested in building leadership capacities in cancer control, do get in touch. The UICC's leadership workstream is supported by For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases. MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. An umbrella foundation associated with the bank Lombard Odier and a registered charity, Fondation Philanthropia has been helping its donors bring their philanthropic initiatives to fruition in all areas of social responsibility since 2008. It provides philanthropic expertise and support to those who wish to develop a philanthropic project in line with their background, desires and ambitions. The Foundation offers its donors a legal, financial and philanthropic framework for made-to-measure projects. The Foundation now operates more than 20 personal funds and has received over 115 million Swiss francs in donations, of which over a third has already been distributed or committed. Its donors have been highly committed to the fight against cancer, with over 15 million spent on the cause. With knowledge support from The McKinsey Cancer Center (McKCC) combines the extensive cross-functional oncology experience of our team with methodologies for generating deep market insights, advanced-analytics platforms, and input from a network of leading external experts. We work to advance cutting-edge oncology innovations (both therapeutic and diagnostic) with pharmaceutical and biotech companies and investors. Approaches we design make it possible for health-care providers to deliver better care, and solutions we propose help health systems and policy makers realize the best possible outcomes for cancer patients. Operating in all geographies, the McKinsey Cancer Center conducts more than 100 client engagements annually across strategy, R&D, business development, marketing and sales, market access and policy, and care-delivery topics. We share our cutting-edge knowledge at international oncology conferences, as well as in peer-reviewed publications and other leading industry journals. Since 1947, CCS Fundraising has empowered many of the world’s greatest organizations to advance some of the most important causes in history. As leading consulting experts in campaign and development strategy, we plan and implement fundraising initiatives to help nonprofit organizations make a bigger impact—locally, nationally, and globally. Lightful's BRIDGE programmes help nonprofits to build resilience in digital growth and engagement ELCA provides high-quality, innovative solutions that help the Swiss transportation industry and mobility providers on their way to digital transformation, ensuring they stay ahead in global competitiveness. Founded in 2008, Stone Soup Consulting is a socially driven international consultancy that works to strengthen organisations that are seeking to increase their social impact. Stone Soup works with several types of organisations through shared processes in strategy creation and implementation. Acting in partnership rather than in a purely advisory role, Stone Soup Consulting is able to help these organisations maximise their social value by identifying possible paths for development and growth. Related pages Fostering an influential cancer community with the skills, knowledge, networks and resources to achieve effective cancer prevention and control. UICC has been supporting the continuing education of cancer control professionals through online learning since 2014. UICC has a long history of building capacity for cancer organisations globally through grant making. Established in 1962, the Fellowships is one of UICC's oldest and most established portfolio of programmes. UICC’s Cancer Advocates programme provides an opportunity for civil society organisations (CSOs) from low- and middle-income countries to gain the skills and knowledge to engage in national advocacy efforts for improved cancer control. The programme is available in English, French and Spanish. UICC's Virtual Dialogues provide members, and the cancer community, with regular opportunities to connect, exchange knowledge, access expert insights, and share solutions from the comfort of one's office or home. Launched in 2018, the Patient Group Mentoring programme is a tailored mentorship programme dedicated to building capacity of a representative cohort of patient groups at the regional level. Tags Leadership Capacity Building Organisational leadership Last update Monday 18 September 2023 Share this page
